%0 Journal Article %B ERJ Open Res %D 2022 %G eng %M 36299367 %R 10.1183/23120541.00211-2022 %T Mortality associated with metabolic syndrome in people with COPD managed in primary care %V 8 %2 PMC9589337 Institute for Health Research (NIHR)/UKRI, a speaker fee from Boehringer, support for attending meetings from Chiesi; and she is ERS Group 01.02 Pulmonary Rehabilitation Secretary (unpaid), all outside the submitted work. J.K. Quint has received grants or contracts from The Health Foundation, MRC, GSK, Bayer, BI, AUK-BLF, HDR UK, Chiesi and AZ; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Chiesi, Insmed and Bayer, all outside the submitted work. K. Khunti has received grants or contracts from Boehringer Ingelheim, AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Amgen, AstraZeneca, Bayer, NAPP, Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Berlin-Chemie AG/Menarini Group, Sanofi-Aventis, Servier and Boehringer Ingelheim, and outside the submitted work. N.J. Greening has received grants or contracts from GlaxoSmithKline and Genentech; consulting fees from Genentech; payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from AstraZeneca, Chiesi and GlaxoSmithKline; and served on a Data Safety Monitoring Committee for Thirty Respiratory Limited, all outside the submitted work. M.C. Steiner has received support for the present manuscript from NIHR Applied Research Collaboration East Midlands and the NIHR Leicester Biomedical Research Centre. The remaining authors have nothing to disclose. %7 2022/10/28 %@ 2312-0541 (Print) 2312-0541